The PGTaiSM Technology Platform
Empowers Clinicians and Patients

The PGTai platform, our revolutionary approach to PGT-A providing clinicians greater confidence in their embryo transfer decisions

More euploids, more confidence, more transfers

By using artificial intelligence, big data and machine learning the PGTai platform provides advanced accuracy in PGT-A analysis, resulting in a greater number of positive outcomes for both patients and clinicians.

Availability

Our innovative PGTaiSM technology platform is clinically available across all CooperGenomics labs.

Contact Us For More Information

PGTai

The PGTai platform is the most innovative and robust test on the market. Since its launch we have observed the following:*

tickResize

More euploid embryos reported
LEARN MORE 

Increase in number of patients with at least one reported euploid embryo
LEARN MORE

tripleResize

Reported an extra 1300+ euploid embryos as a result of this innovation
LEARN MORE

Only platform in the field built on live births and sustained pregnancy outcomes.
LEARN MORE

*CooperSurgical internal data: prior (subjective) methodology, Jan 1, 2018 through Nov 1, 2018 vs PGTai technology platform, Nov 2, 2018 through May 31, 2019

Available through our US labs

PGTai 2.0: Dedicated to advancing accuracy in PGT-A

We are proud to announce that our already best-in-class PGTai technology platform is about to get even more accurate

By introducing single nucleotide polymorphism (SNP) analysis and paired-end sequencing, PGTai 2.0 provides even more robust PGT-A interpretation. This analysis interrogates DNA sequence variation (a SNP is one type) that originates from the parental gamete genomes. Most importantly for clinicians and patients, this means the platform will deliver added accuracy, thus allowing for prioritization with more confidence.

Download Our PGTai 2.0 Brochure
Download Our PGTai 2.0 White Paper

Clinic Testimonials

testimonials-icon

At CARE Fertility, we have been impressed with the transition from standard to PGTai; the staff education and clarity of reporting. In addition, we are reassured by the increased precision of this test and believe it brings benefits for our patients.

Alison Campbell
Director of Embryology, CARE Fertility Group, London, UK

The switch to PGTai has more than halved the turnaround time on our results, with the lab now averaging 3 days from sample receipt to providing us with the final report. That’s been an enormous benefit, those extra few days waiting for results make a huge difference to our patients! We’ve seen a drop in the number of ‘no call’ results since the changeover to below 2%. Most importantly the level of service from the staff we deal with in the UK laboratory has been outstanding, always friendly, helpful and on top of anything we need.

Kelli Sorby
Scientific Director, Number1 Fertility, Melbourne, Australia

whitePaper-icon

Download our PGTai Technology Platform White Paper

Click Here

whitePaper-icon

Download our PGTai 2.0 Technology Platform White Paper

Click Here

Watch Our Webinars

Since the launch of the PGTai Technology Platform we have observed the following:*

More euploid embryos

In the first seven months of reporting results through the PGTai platform, we have reported more euploid embryos, thus providing clinicians with greater transfer opportunities.

Examples of reported ploidy rates using prior methodology/subjective interpretation vs the PGTai platform

ClinicAgraph

clinicBgraph

With prior (subjective) methodology

Euploid Rates

Mosaic Rates

Aneuploid

With the PGTai Platform

Euploid Rates

Mosaic Rates

Aneuploid

Sample sizes are shown alongside the data bars in the format (n=prior [subjective] methodology/PGTai platform)

More patients with at least one euploid embryo

Since the launch of the PGTai platform, we have also observed an increase in the percentage of patients reported with at least one euploid embryo, providing patients of all age ranges with a greater chance at a euploid embryo transfer.

Patients with at least one euploid embryo reported with PGTai technology vs previous methodology

Prior (subjective) methodology

PGTai technology

Sample sizes are shown alongside the data bars in the format (n=prior [subjective] methodology:PGTai platform)

More than 1300 extra euploid embryos reported

We have reported an extra 1300+ euploid embryos as a result of the PGTai platform, which previously would have been reported as aneuploid or mosaic.

Net change observed in ploidy classification using prior methodology/subjective interpretation vs the PGTai platform

*CooperSurgical internal data: prior (subjective) methodology, Jan 1, 2018 through Nov 1, 2018 vs PGTai technology platform, Nov 2, 2018 through May 31, 2019

PGTai Technology Platform

CooperGenomics-technology

A revolution in PGT-A analysis

The PGTai technology platform is the most innovative and robust test in the market and the only platform in the market built from a known data set of live births and sustained pregnancy outcomes.

Over the years, advances in technology have played a pivotal role in the evolution of PGT. These technological innovations have driven improvements in accuracy, sensitivity and specificity of PGT-A results. We are proud to be driving the next leap in PGT-A technology. The PGTai platform is a ground-breaking algorithm that harnesses the power of big data using a massive reference set to maximize PGT-A calling, interpretation and reporting.

Key features of the PGTai technology platform

Innovative tool that leverages the data accumulated over the history of PGT-A at CooperGenomics
• Only analysis platform in the field built from a truth data set of live births and sustained pregnancy outcomes
• Allows transfer decisions based on mathematical and statistical predictions, removing the limitation of human interaction,  subjectivity, and error
• Employs machine learning to enable continuous controlled improvement
• Improves signal clarity, to increase accuracy and ensure optimal sensitivity and specificity

Existing Technology

Existing-technology

How the PGTai technology platform is revolutionizing PGT-A

CooperGenomics PGTai Other
Algorithm built on/validated on >1,000/>10,000 ~100/?
Modeled on live births and sustained pregnancy outcomes
X
Detects mosaicism
, 20-80%
Some, varies
Removes human subjectivity
X
Minimizes human (interpretation & transcription) error
X
Platform Custom/Dynamic Off the shelf/Static
Can be performed without ICSI
Some